Statement of Dr. Larry Corey on the Results of the iPrEx Study of HIV Prevention

The HVTN released a statement on the iPrEx study results, stating that "PrEP is an exciting addition to the “toolbox” of HIV prevention strategies."  The full statement is available below.

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account